How Patel was paid
$5.8M in total for 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Sushil PatelChief Executive Officer | $700,000 | $3,376,003 | $1,448,325 | $315,000 | $6,654 | $5,845,982 |
| Emily HillChief Financial Officer | $532,000 | $970,800 | $393,451 | $196,320 | — | $2,092,571 |
| Konstantinos XynosChief Medical Officer | $536,000 | $970,800 | $393,451 | $198,320 | $14,210 | $2,112,781 |
What changed and why
- $5.8M$5,845,982 was CEO total compensation in 2026, compared with $3,697,661 in 2025.
- $3.4M$3,376,003 was the CEO’s stock-award value, including performance RSUs shown at target attainment.
- 75%75% of the CEO’s 60% target bonus opportunity was awarded for 2026.
- 92.5%92.5% of the CFO’s and CMO’s 40% target bonus opportunities were awarded for 2026.
- Annual incentives reflected significant progress toward many corporate goals and individual objectives.
- Base salary, annual cash incentives and long-term equity incentives remained the program’s three main components.
Other Replimune Group proxy statements
- 2025 proxy statement
Sushil Patel paid $3.7M (+79% on the year).
Filed Jul 25, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.